HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

NorthCrest Asset Manangement, LLC's Holding History (CIK: 0001893159)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 31,414 Value ($000) $2,237 Avg Close $67.27 Range $61.23 - $76.30
Q3 2025
Shares 30,553 Value ($000) $2,017 Avg Close $66.43 Range $51.78 - $79.50
Q2 2025
Shares 21,857 Value ($000) $1,180 Avg Close $56.90 Range $47.50 - $70.51
Q1 2025
Shares 29,879 Value ($000) $1,907 Avg Close $58.09 Range $47.52 - $66.00
Q4 2024
Shares 29,859 Value ($000) $1,428 Avg Close $51.28 Range $42.01 - $62.13
Q3 2024
Shares 29,852 Value ($000) $1,709 Avg Close $57.33 Range $50.68 - $65.53
Q2 2024
Shares 29,852 Value ($000) $1,563 Avg Close $43.86 Range $37.73 - $53.00
Q1 2024
Shares 29,852 Value ($000) $1,214 Avg Close $37.49 Range $33.15 - $42.64
Q4 2023
Shares 36,824 Value ($000) $1,361 Avg Close $37.66 Range $32.83 - $42.82
Q3 2023
Shares 36,824 Value ($000) $1,407 Avg Close $40.96 Range $35.71 - $45.00
Q2 2023
Shares 36,824 Value ($000) $1,328 Avg Close $34.12 Range $29.85 - $38.80
Q1 2023
Shares 36,824 Value ($000) $1,406 Avg Close $46.91 Range $32.83 - $57.00
Q4 2022
Shares 23,650 Value ($000) $1,346 Avg Close $51.20 Range $39.17 - $59.46
Q3 2022
Shares 23,500 Value ($000) $929 Avg Close $44.20 Range $38.03 - $52.98
Q2 2022
Shares 23,500 Value ($000) $1,034 Avg Close $43.25 Range $36.95 - $48.58
Q1 2022
Shares 23,500 Value ($000) $937 Avg Close $35.62 Range $31.36 - $42.33
Q4 2021
Shares 10,500 Value ($000) $422 Avg Close $37.33 Range $31.79 - $41.20